Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02220192 · ClinicalTrials.gov registry record · NA
An Alternative Treatment for Cervical Intraepithelial Neoplasia Using the Focal Loop Electrosurgical Excision Procedure
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02220192 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 11 participants.
The verdict
NCT02220192, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This is a pilot study to test the short-term effectiveness of an alternative treatment approach for precancerous cells of the cervix. The study will also explore whether this new treatment is feasible to perform and if it is acceptable to patients.
Interventions
- PROCEDURE Focal LEEP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02220192
The ClinicalTrials.gov registry entry for NCT02220192 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Focal LEEP is the first listed.
NCT02220192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02220192 about?
NCT02220192 is a clinical study titled "An Alternative Treatment for Cervical Intraepithelial Neoplasia Using the Focal Loop Electrosurgical Excision Procedure". This is a pilot study to test the short-term effectiveness of an alternative treatment approach for precancerous cells of the cervix. The study will also explore whether this new treatment is feasible to perform and if it is acceptable to patients.
What is the current status of trial NCT02220192?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-12. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02220192?
The interventions under investigation include: Focal LEEP (PROCEDURE).
Who is sponsoring clinical trial NCT02220192?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.